PMS2 Postmeiotic Segregation Increased 2 (S. Cerevisiae) (PMS2) Peptide
PMS2
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN939460
Quick Overview for PMS2 Postmeiotic Segregation Increased 2 (S. Cerevisiae) (PMS2) Peptide (ABIN939460)
Target
PMS2
(PMS2 Postmeiotic Segregation Increased 2 (S. Cerevisiae) (PMS2))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- INKKVVPLDF SMSSLAKRIK QLHHEAQQSE GEQNYRKFRA KICPGENQAA
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PMS2 antibody,
Alternative Names: PMS2 control peptide, PMS2 antibody Blocking Peptide, Anti-PMS2 Blocking Peptide, Pms2 Postmeiotic Segregation Increased 2 Blocking Peptide, HNPCC4 Blocking Peptide, PMS2CL Blocking Peptide, PMSL2 Blocking Peptide, PMS2, PMS-2, PMS 2, PMS-2 Blocking Peptide, PMS 2 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- PMS2 (PMS2 Postmeiotic Segregation Increased 2 (S. Cerevisiae) (PMS2))
-
Background
- PMS2 is involved in DNA mismatch repair. It forms a heterodimer with MLH1 and this complex interacts with other complexes bound to mismatched bases. Mutations in this gene are associated with hereditary nonpolyposis colorectal cancer, Turcot syndrome, and are a cause of supratentorial primitive neuroectodermal tumors.
-
Molecular Weight
- 96 kDa
Target
-
You are here:
